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A clearly-framed question creates the structure and delineates the approach to defining research 
objectives, conducting systematic reviews and developing health guidance [1, 2]. To assess the 
association between exposures and outcomes, including in the field of nutrition, environmental 
and occupational health, the concept of defining the Population (including animal species), 
Exposure, Comparator, and Outcomes (PECO) as pillars of the question is increasingly accepted 
[3, 4]. Thus, the PECO defines the objectives of the review or guideline. Furthermore, the PECO 
informs the study design or inclusion and exclusion criteria for a review, as well as facilitating 
the interpretation of the directness of the findings based on how well the actual research findings 
represent the original question. 
Previously, we have recognized the importance of PECOs for directing the assessments of 
benefits and harms, identification of exposures as risk factors or within risk assessments, and 
evaluation of the impact of interventions that prevent or mitigate an exposure or risk [3]; 
however, in debating PECO questions in our work, we found no guiding framework for 
operationalizing the PECO approach and the types of PECO questions researchers and decision-
makers can answer. We identified only limited indirect guidance based on the development of 
Population, Intervention, Comparator, and Outcomes (PICO) questions where the general 
concept originated [1]. The Cochrane Collaboration emphasizes the importance of a well-
formulated research question to guide an intervention review and provides clarity about the 
individual PICO components [5]; however, a review of 313 research studies reported that over 

























































In environmental, public and occupational health research, specific challenges exist with 
identifying the exposure and comparator within the PECO. In fact, in these fields there are 
fundamental differences to formulating questions about interventions and comparators in the 
PICO framework [1]. The Cochrane Handbook, widely recognized as reference guide for 
systematic reviews, does not specifically address the development of questions for reviews of 
exposures [5]. Other organizations have reported adapting PICO to PECO for studies of 
unintentional exposure [7-9]. For example, the Collaboration for Environmental Evidence 
recognizes the transition from PICO to PECO for questions about the effect of an exposure [7]. 
The Navigation Guide, the National Toxicology Program’s Office of Health Assessment and 
Translation, the U.S. Environmental Protection Agency’s (EPA) Integrated Risk Information 
System (IRIS) and the European Food and Safety Association (EFSA) emphasize the role of the 
PECO question to guide the systematic review process for questions about exposures [8-10]. 
EFSA also proposes a back-calculation of PECO elements to define an exposure (if the effect on 
the outcome is known among a determined population) [10]. Typically review authors have used 
approaches to PECO questions that are reflective of two of the scenarios that we will present, 
specifically cases where the research question aims to evaluate whether an exposure is associated 
with a health outcome(s). However, the PECO can also be focused in ways that can make the 
systematic review perhaps better suited to inform decision-makers and these are illustrated in 
three scenarios we will present. These latter PECO approaches are seldom used; in part this may 
be due to the fact that a fully developed framework for operationalizing the development of 
PECO questions does not exist. 
Given the lack of such guidance, research studies and systematic reviews often fail to explicitly 

























































question, the purpose of the research is more clearly defined for the reader. For example, a recent 
systematic review broadly explored whether or not exposure to serum or plasma 
perfluorooctanoic acid (PFOA) among humans before or during pregnancy is associated with 
fetal growth [11]. The authors reported that a 1 ng/mL increase in serum or plasma 
perfluorooctanoic acid (PFOA) is associated with an 18.9 g decrease in birth weight. The review 
appropriately specified the population, exposure, comparator and outcome and it focused on 
exploring the presence or absence of an association. This approach is often chosen when little is 
known about the exposure and its potential relationship to an outcome. An alternative way to 
characterize with the impact of PFOA on health outcomes could better inform decision-makers. 
For instance, one might ask which exposure level would lead to a dangerous decline in birth 
weight or negative health outcomes in this population. If pursuing this strategy, evidence would 
be needed to define the outcome of interest; in this example, although challenging, the protocol 
would need to qualify the level of decline in birth weight that is considered harmful. Neither of 
the two former approaches is superior or inferior; they simply describe different research 
questions or phases in exploring the impact of exposures on outcomes. In fact, the general 
approach to phrasing PECO questions will depend on a number of factors, including a) the 
context; and b) what might be known about the effects of an exposure on an outcome at a given 
time. However, because of the dependence on the research and decision-making context, 
clarifying these aspects for the purpose of developing a PECO is crucial.
To address these issues, we developed a framework to formulate PECO questions that includes 
five paradigmatic scenarios. These scenarios are common for researchers conducting individual 
studies and authors of systematic reviews. Our framework proposes solutions with examples 

























































strong focus on the ‘E’ and ‘C’ domains (Table 1). This is because we consider defining the 
population (including animal populations) and outcomes as more straightforward given their 
relation to the existing PICO literature. We attempted to support our framework by examples.
Furthermore, for practical reasons our primary focus is on environmental health and we drew on 
selected examples from these fields; however, these scenarios are relevant to other disciplines, 
including broader public health questions and nutrition. Since the exploration of the existence of 
an association between an exposure and a comparator is the building block for any further 
evaluation, we will describe that scenario first. We follow with scenarios in which this evaluation 
has been done or, for some scenarios, the decision-making context may be known. As stated 
above, none of the approaches is superior to another and they are influenced by the context of 
what is known as we will lay out in this brief article.
Insert Table 1.
Quantifying the exposure
Research to understand and quantify the exposure is needed to properly address scenarios 2 to 5 
and formulate the PECO questions for them. In our first scenario, we describe what typically 
precedes those scenarios when little or nothing is known about the relationship between an 
exposure and outcome. Research addressing this scenario can provide information on the mean 
levels of exposure, ranges of exposures, and the nature of the association with the health 
outcome. In fact, for many organizations these are the most common questions asked. We will 
then present the remaining four scenarios with the assumption that research informing scenario 1 

























































To implement the framework, researchers can utilize a number of sources to inform and facilitate 
the quantification of an exposure and, specifically, to define the criteria for the comparator. We 
refer to this in many examples as a cut-off value. We use the term cut-off to broadly to refer to 
thresholds, levels, durations, means, medians, or ranges of exposure. In this commentary, our 
examples are informed by previously published primary research or systematic reviews and 
government identified thresholds (e.g. Occupational Safety Health Administration [OSHA]); 
however, other sources may include current legislation or a level which is considered to produce 
a minimally-important change.
PECO Scenario 1
The first scenario facilitates the identification of a comparison when little or nothing is known 
about the association between exposure and the outcome, including the nature of the relationship. 
This PECO, as stated one of the most common situations in environmental health, aims to 
explore the impact of different levels of exposure on health outcomes and the nature of the 
relationship. The comparator includes the entire range of exposures (e.g. an incremental increase 
in exposure). Here, all comparators are predefined by what the observed data will show. The 
objective may be to define whether or not there is an association between the exposure and 
health outcome and, if there is an association, to identify the nature of the relationship, e.g., 
linear, logarithmic or u-shaped. For example, we present a summary of the results from two 
systematic reviews wherein this explorative PECO scenario leads to differing findings. In the 
first, a systematic review examined the association between 10 ng/mL increments of exposure to 
vitamin D and a range of health outcomes, including prostate cancer. The review reported no 
association between the 1,25(OH)2D biomarker to measure vitamin D with development of 

























































to particulate mass with aerodynamic diameter less than 2.5µm (PM2.5) and suggested a positive 
linear relationship with mortality from stroke [13]. 
In conjunction with Table 1, we provide additional examples to illustrate these scenarios using 
the topic of hearing impairment. To explore postnatal hearing impairment as a result of prenatal 
noise exposure, one may choose to examine an incremental increase in decibel (dB) exposure. 
Research suggests a linear dose-response relationship between the level of noise (i.e. dBs), 
duration of exposure, and health outcome of hearing impairment [14]; however, little is known 
about the effect of prenatal noise exposure on newborn hearing impairment [15]. Since there is 
insufficient information to isolate a specific comparison when examining prenatal noise 
exposure, we would develop a PECO that explores the association between incremental increase 
in exposure and hearing impairment. The size of the increments of the comparator may be 
informed by existing rationale or, if no evidence exists, they may require a more arbitrary 
identification. When developing a scenario about prenatal noise exposure, we present a 
hypothetical PECO question to reflect this situation, understanding that the ‘E’ and the ‘C’ could 
represent different values or smaller increments to measure change in the outcomes. For this 
example, we derived the incremental increase from the OSHA’s Standardized Threshold Shift 
for occupational noise exposure of 10 dB [16].
P: Among newborns, what is the effect of
E: 10 dB exposure to noise during gestation versus
C: 10 dB incremental increase on

























































PECO Scenario 2 
In the second scenario, we are interested in comparing health effects of different exposure levels 
but either do not know naturally occurring exposure levels or are unsure about which cut-offs to 
choose. This scenario is often a direct consequence of scenario 1 and may be addressed in the 
same systematic review as scenario 1 from which it would follow. Scientists often present data in 
ordinal groups (e.g. quartiles) in such situations. For example, we previously reported the effects 
of different levels of antioxidant blood and serum levels on pulmonary function and respiratory 
health [17-19]. The choice for the exposure and comparator in a systematic review may therefore 
be based on measures of distribution of the exposure in the included studies (e.g., central 
tendency values; highest versus lowest exposure groups such tertiles, quartiles, or quintiles). 
Ideally, the included studies describe the rationale for presentation of the exposure distribution to 
facilitate defining the cut-offs for the systematic review. This scenario requires exploration of the 
data to determine the specific exposure and comparator. It requires iterative development of the 
PECO based on findings from the systematic review or information from risk-management 
conclusions, which, nevertheless, should be pre-specified in a protocol. An additional example 
examines the effect of prenatal exposure to noise on postnatal hearing impairment.
P: Among newborns, what is the effect of
E: Highest noise exposure during pregnancy versus
C: Lowest noise exposure during pregnancy on

























































In addition, this second scenario could be informed by baseline risk data from a population-level 
study that allows specifying the exposure of the comparison. For example, by using the 
disaggregated population-weighted mean concentrations of PM2.5 [20]. 
PECO Scenario 3
Our third scenario addresses formulating a PECO question in which we might have information 
about a certain exposure level for a population of interest but want to compare that to the impact 
of a different level of exposure on a certain health outcome. In this situation the mean cut-offs 
from an external or general population (from other research) may serve as the comparator. For 
example, we may be interested in comparing the impact of exposure to PM2.5 from one country 
to either a different country or a global mean. To do this we could use the data reporting PM2.5 
levels on the outcome of airflow obstruction from a nationally-representative survey in China as 
our exposure and outcome of interest. The comparator could then be informed by either the mean 
concentration of PM2.5 levels in a different country or the global population-weighted mean 
concentration of PM2.5 levels [20]. The systematic review would address the following PECO: 
“In people exposed to particulate matter, what is the impact of levels of exposure identified in 
China compared to other countries or the global mean on airflow obstruction?” Of course, the 
ensuing analyses would have to carefully account for potential covariates or confounders.
A second example focuses on the impact of noise exposure among commercial pilots on hearing 
impairment exposure-level estimates from a cohort study conducted in Sweden [21]. To compare 
the risk of hearing impairment among commercial pilots with other occupations or the general 
population, we could conduct a systematic review of the effects on hearing impairment using a 

























































P: Among commercial pilots, what is the effect of
E: Noise corresponding to their occupational exposure versus
C: Noise exposure experienced by people in low-exposure occupations on
O: Hearing impairment.
PECO Scenario 4
In the fourth scenario, we may have sufficient information about the exposure and outcome to 
quantify a dose-response relation. Specifying the exposure and comparator will include using 
existing exposure cut-offs (e.g., thresholds, levels, durations, means, medians, or ranges of 
exposure) associated with the health outcomes of interest. For example, we may want to explore 
long-term exposure to occupational noise levels greater than 80 dB, which increase the risk of 
hearing impairment compared to lower levels [22]. 
P: Among industrial workers, what is the effect of
E: Occupational noise exposure < 80 dB versus
C: Occupational noise exposure ≥ 80 dB on
O: Hearing impairment.
The difference between this and the next scenario lies in the exploration (i.e. comparison) of 
what an intervention can achieve and outcomes that are associated with defined exposure levels. 
In other words, the PECO elements may be driven by the difference between a context which is 

























































context concerned with estimating the potential efficacy of an intervention to modify an 
exposure and the outcome which is the topic of our fifth and last scenario.
PECO Scenario 5
The fifth scenario typically occurs when there is evidence suggesting an association between an 
exposure and the outcome, such as the research suggesting a dose-response relationship between 
the level of noise and health outcome of hearing impairment referenced previously [14] (based 
on a PECO following scenario 1, table 1). If a decision-maker is interested in a specific exposure 
cut-off or intervention to mitigate the exposure through known interventions, they will ask 
systematic reviewers to conduct a review using the PECO framework that appropriately 
describes the health effects of exposures that are achievable or realistic in relation to a 
comparator.
A policy maker may want to know, in the absence of evidence evaluating the impact of an 
intervention or in the context of new interventions for which high certainty evidence is available, 
what the potential impact of that intervention is on health effects. As direct evidence evaluating 
the intervention is not available, the exposure cut-offs in the PECO question would be informed 
by the implementation of an intervention (e.g. the potential introduction of a novel street surface 
that can reduce noise levels by 20 dB) compared to not implementing the intervention. Note that 
this will still only provide indirect evidence for the effects of the intervention but can be helpful 
for modelling the impact if intervention studies are not available. The discrete PECO formulation 
of this example would be as follows:
P: Among the general population, what is the effect of

























































C: Current noise levels on
O: Hearing impairment.
Summary and conclusions
Formulating informative questions is a prerequisite for conducting an evidence synthesis in 
systematic reviews. The PECO approach to question formulation supports the conduct of a 
systematic review, including formulating search and eligibility criteria, presenting outcomes, and 
the wording in guidelines of final recommendations. We found little guidance about how to 
formulate questions that deal with unintentional exposures and, therefore, developed a 
framework based on existing examples and in-depth discussion that will help those designing 
research studies and authors of systematic reviews dealing with all populations and outcomes. 
Our framework supports understanding the nuances and differences that exist between the review 
(research) question, the subsequent and sometimes iterative definition of inclusion and exclusion 
criteria from the PECO (they may or may not cover the PECO very narrowly or broadly) and the 
interpretation of the directness of the identified evidence. The framework can also provide 
guidance for those conducting individual studies dealing with exposures. We recognize that 
additional considerations would be required to develop a PECO framework aimed at animal 
studies or systematic reviews that include consideration of epidemiological and animal studies to 
discern whether a chemical has an effect on a health outcome. We encourage further testing and 
feedback on the use of this framework and include Figure 1, as a brief guide to facilitate the 
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Table 1. Five paradigmatic approaches and examples for identifying the exposure and 
comparator in systematic review and decision-making questions
Potential systematic-
review or research context
Approach PECO example
1. Calculate the health 
effect from an exposure; 
describing the dose-effect 
relationship between an 
exposure and an outcome 
for risk characterisation.
Explore the shape and distribution 
of the relationship between the 
exposure and the outcome in the 
systematic review. 
Among newborns, what is the 
incremental effect of 10 dB 
increase during gestation on 
postnatal hearing impairment?
2. Evaluate the effect of an 
exposure cut-off on health 
outcomes, when the cut-off 
can be informed iteratively 
by the results of the 
systematic review.
Use cut-offs defined based on 
distribution in the studies 
identified in the systematic review. 
Among newborns, what is the 
effect of the highest dB 
exposure compared to the 
lowest dB exposure (e.g. 
identified tertiles, quartiles, or 
quintiles) during pregnancy 
on postnatal hearing 
impairment?
3. Evaluate the association 
between an exposure cut-off 
and a comparison cut-off, 
when the cut-offs can be 
identified or are known 
from other populations.
Use mean cut-offs from external or 
other populations (may come from 
other research). 
Among commercial pilots, 
what is the effect of noise 
corresponding to occupational 
exposure compared to noise 
exposure experienced in other 
occupations on hearing 
impairment?
4. Identify an exposure cut-
off that ameliorates the 
effects on health outcomes.
Use existing exposure cut-offs 
associated with known health 
outcomes of interest. 
Among industrial workers, 
what is the effect of exposure 
to < 80 dB compared to ≥ 80 
dB on hearing impairment?
5. Evaluate the potential 
effect of a cut-off* that can 
be achieved through an 
intervention to ameliorate 
the effects of exposure on 
health outcomes.
Select the comparator based on 
what exposure cut-offs can be 
achieved through an intervention. 
Among the general 
population, what is the effect 
of an intervention that reduces 
noise levels by 20 dB 
compared to no intervention 
on hearing impairment?
* Cut-offs is a broad term referring to thresholds, levels, durations, ranges, means, medians, or 
ranges of exposure. dB: decibel; PECO: population, exposure, comparator, outcome(s).
